Cite Filings / DNTH / 0000919574-26-005203

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Dianthus Therapeutics, Inc. /DE/ Filed 2026-08-14 Acc 0000919574-26-005203

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-08-14 4 SVP, General Counsel and Sec. acquired 15,000 shares (option exercise)
2026-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-08-13 SCHEDULE 13G Statement of Beneficial Ownership
2026-08-11 4 Director sold 7,750 shares at an average $109.01 ($844,822)
2026-08-11 4 SVP, General Counsel and Sec. sold 20,000 shares at an average $110.44 ($2,208,833)
2026-08-11 4 Director sold 2,777 shares at an average $109.55 ($304,232)
2026-08-07 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…